Sbi Securities Co., Ltd. Celldex Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 30 shares of CLDX stock, worth $698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$698% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
66MCall Options Held
1.68MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$215 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$90.1 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$80.6 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$77.6 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.09B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...